Argan stock jumps 16% into a long weekend — here’s what traders will watch next
18 January 2026
1 min read

Argan stock jumps 16% into a long weekend — here’s what traders will watch next

NEW YORK, Jan 18, 2026, 07:08 ET — Market closed

  • Argan shares leapt 16.4% on Friday, closing at $383.66 after hitting an intraday high near $392.
  • U.S. stock markets are shut Monday for Martin Luther King Jr. Day, pushing the next cash session to Tuesday.
  • Short interest in AGX fell in the latest reporting period, a sign some bearish bets were pared back.

Argan, Inc. shares surged 16.4% on Friday, finishing at $383.66 after swinging between $335.53 and $392.48, according to Yahoo Finance data. 1

The jump left traders heading into a long weekend with little time to chase the move. U.S. equity markets are closed on Monday for Martin Luther King Jr. Day and reopen on Tuesday. 2

One read-through for investors: the stock’s sharp burst came as short interest eased in the latest settlement-date report. Short interest measures the number of shares borrowed and sold by investors betting the price will fall; it fell about 20% to 521,702 shares as of Dec. 31, MarketBeat data showed. 3

Argan, based in Arlington, Virginia, provides engineering, procurement and construction work — “EPC” — and related services, with a heavy tilt to power projects. In its most recent quarterly update, the company reported project backlog — contracted work not yet performed — of about $3.0 billion as of Oct. 31, and said it had no debt; CEO David Watson said the company was “optimistic about our ability to drive revenue growth and enhanced profitability.” 4

The move also landed in a corner of the market that can gap fast. Quanta Services rose about 4% in the last session, Fluor added roughly 1%, while KBR edged lower, market data showed.

Investors are also looking at income dates. Argan declared a regular quarterly cash dividend of $0.50 per share, payable Jan. 30 to shareholders of record on Jan. 22; Watson said returning cash to shareholders “remains a key tenet” of the company’s capital plan. 5

But the same things that drive the upside can cut the other way. Argan’s results can be lumpy because project timing shifts, and backlog does not guarantee smooth revenue if permits, labor or equipment snag.

For Tuesday’s reopen, traders will be watching whether Friday’s rally holds without fresh catalysts, and whether volume follows through. The next near-term calendar marker is Jan. 22 for the dividend record date, with any contract headlines or filings likely to set the tone in between.

Stock Market Today

CleanSpark stock price jumps 22% after earnings and AI push — what CLSK traders watch next week

CleanSpark stock price jumps 22% after earnings and AI push — what CLSK traders watch next week

7 February 2026
New York, Feb 7, 2026, 09:51 EST — Market closed. CleanSpark, Inc. shares closed up about 22% on Friday at $10.08, giving the bitcoin miner and data-center developer a sharp rebound heading into the weekend. The move followed the company’s fiscal first-quarter results and a renewed pitch to build out “AI-ready” power and land. CEO Matt Schultz said the company had “secured up to 890 megawatts” of utility-grade power capacity in the Houston region, while CFO Gary Vecchiarelli said CleanSpark was “no longer a single-track business.” 1 Why this matters now: bitcoin is still setting the tempo for the group,
Nu stock jumps to $17.40 as traders eye Nubank’s next catalyst

Nu stock jumps to $17.40 as traders eye Nubank’s next catalyst

7 February 2026
Nu Holdings shares climbed 3.5% to $17.40 Friday, reversing Thursday’s loss, as the Dow closed above 50,000 for the first time. Nu recently received conditional approval from U.S. regulators to form a national bank, but still needs further sign-offs before launching. The company manages $38.8 billion in deposits and reports earnings Feb. 25.
Rocket Companies stock heads into holiday week as yields rise — what RKT investors watch next
Previous Story

Rocket Companies stock heads into holiday week as yields rise — what RKT investors watch next

Why ImmunityBio stock jumped nearly 40%: ANKTIVA sales surge and a fresh trial timeline
Next Story

Why ImmunityBio stock jumped nearly 40%: ANKTIVA sales surge and a fresh trial timeline

Go toTop